(101) found that, in the STZ-induced rat diabetes model, hucMSC-sEVs injected via the tail vein inhibited the secretion of pro-inflammatory cytokine TNF-α to reverse T2DM IR and indirectly increased the insulin/AKT signaling pathway activation. The gene discussed is TNF; the disease is diabetes mellitus.